Targeted Drug Delivery System for Platinum-based Anticancer Drugs

Area of Science:

• Oncology
• Pharmacology
• Drug Delivery Systems

Background:

• Platinum-based (Pt-based) anticancer drugs are effective against various tumors.
• Limitations include side effects, drug resistance, and lack of specific targeting.
• These limitations hinder the broader clinical application of Pt-based drugs.

Purpose of the Study:

• To review recent advancements in targeted drug delivery techniques for Pt-based anticancer drugs.
• To explore strategies for overcoming the limitations of current Pt-based therapies.
• To highlight opportunities for developing more effective and less toxic Pt-based drugs.

Main Methods:

• Review of current literature on targeted drug delivery systems (TDDS) for Pt-based drugs.
• Analysis of various TDDS approaches, including nanoparticle, polymer, and macrocyclic compound systems.
• Focus on recent developments and their potential impact on drug efficacy and toxicity.

Main Results:

• Various TDDS have been investigated to improve the antitumor activity of Pt-based drugs.
• Nanoparticle, polymer-drug, and drug-macrocyclic compound systems are among the explored TDDS.
• These systems aim to enhance drug targeting, reduce side effects, and overcome resistance.

Conclusions:

• Targeted drug delivery systems (TDDS) represent a promising strategy for novel Pt-based anticancer drug development.
• TDDS can potentially improve the efficiency and reduce the toxicity of Pt-based drugs.
• Further research into TDDS offers opportunities to overcome drug resistance and expand clinical applications.